Debilitating headaches are reducing their quality of life, but doctors say taking these steps can help.

Wegovy, a weight loss drug, is gaining popularity for its effectiveness, but experts emphasize that it's most successful when ...

A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...

This change is happening because there’s another covered medication that’s safe and effective for your condition and may cost ...

Novo Nordisk has submitted a new, higher dose of its obesity treatment, Wegovy, for approval to the European Medicines Agency ...

A study in Diabetes, Obesity and Metabolism has identified certain characteristics that might influence people's weight loss ...

That's why in July she is planning to transition to Wegovy. It is a weekly injectable weight loss medication with a celebrity aura that is available from 1 July in New Zealand after years of overseas ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the weight-loss drug.

The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.

Novo Nordisk NOVO.B 2.82% plans to expand access to Wegovy through a collaboration with WeightWatchers, days after ending a partnership with telehealth firm Hims & Hers to sell the weight-loss drug.

San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership with weight-loss drugmaker Novo Nordisk abruptly ended.